BUZZ-Australia's Nanosonics rises on U.S. FDA clearance for disinfection product
Reuters
Aug 06
BUZZ-Australia's Nanosonics rises on U.S. FDA clearance for disinfection product
** Shares of Nanosonics NAN.AX rise as much as 11.8% to A$4.35, their highest level since June 16
** Stock set for best day since March 20
** Infection prevention company gets U.S. Food and Drug Administration (FDA) clearance for its latest generation of trophon technology, meant to be used as a disinfection system during ultrasound probes
** Clearance will allow co to launch trophon3 and trophon2 Plus in the United States, representing opportunity to install around 30,000 devices in total
** YTD, stock up 32.6%
(Reporting by Shruti Agarwal in Bengaluru)
((Shruti.Agarwal@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.